Introduction Esophageal squamous cell carcinoma is a highly aggressive malignancy where early detection and accurate assessment of invasion depth are critical for determining optimal treatment strategies. Current tools such as magnifying endoscopy and endoscopic ultrasonography (EUS) are effective but operator-dependent.
Introduction
Esophageal squamous cell carcinoma is a highly aggressive malignancy where early detection and accurate assessment of invasion depth are critical for determining optimal treatment strategies. Current tools such as magnifying endoscopy and endoscopic ultrasonography (EUS) are effective but operator-dependent. Advances in deep learning offer an opportunity to enhance diagnostic accuracy through automated image analysis.
Problem Statement
Existing diagnostic methods for early ESCC are limited by variability in expertise and lack a reliable, integrated system for simultaneous detection and invasion depth assessment.
Summary
This study introduces MUMA-EDx, a novel multimodal deep learning model that integrates magnifying endoscopy and EUS imaging to improve both detection and staging of early ESCC. The model was trained on a large retrospective dataset and validated prospectively, demonstrating excellent performance.
For tumor detection, the model achieved outstanding accuracy with an AUC of 0.94 in retrospective validation and 1.00 in prospective testing. For invasion depth classification—a more complex and clinically critical task—the model maintained strong performance, outperforming novice endoscopists and approaching expert-level accuracy.
The key innovation lies in combining multiple imaging modalities, which significantly improved diagnostic precision compared to single-modality approaches. Clinically, this tool has the potential to standardize ESCC diagnosis, reduce operator dependency, and guide more accurate treatment decisions.
Key takeaway: Multimodal AI can match expert performance and may redefine early cancer detection and staging in endoscopy.
Introduction: Artificial intelligence is rapidly transforming healthcare through drug discovery, clinical decision support, remote monitoring, and administrative automation. While AI is widely expected to reduce healthcare costs, this perspective argues that current payment models and...
Introduction: Large frontier AI models such as GPT-5 and Gemini have achieved impressive results across numerous healthcare benchmarks. However, high benchmark scores alone may not reflect real-world clinical reliability. This study systematically evaluated the robustness...
Introduction: Artificial intelligence is rapidly transforming medicine, but its influence extends far beyond healthcare. This JAMA AI Conversations article explores how AI ethics has become a global societal issue, engaging technology leaders, policymakers, healthcare professionals,...
Introduction: Artificial intelligence is rapidly transforming oncology, evolving from image interpretation and pathology analysis to supporting complex clinical decision-making. This perspective argues that AI should enhance the capabilities of oncologists rather than replace their expertise....
Introduction Clinical trial endpoints have traditionally relied on expert human interpretation, particularly for pathology-based outcomes. However, variability between observers, cost, and time remain important limitations. This NEJM AI perspective discusses how artificial intelligence is beginning...
Introduction: As artificial intelligence becomes increasingly integrated into clinical practice, an important question arises: should AI assistants be regulated as medical devices or viewed as evidence-based clinical methodologies? This NEJM AI perspective proposes a new...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.